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Intensified ambulatory cardiology 
care: effects on mortality 
and hospitalisation—a comparative 
observational study
Olga A. Sawicki1*, Angelina Mueller1, Anastasiya Glushan1, Thorben Breitkreuz2, 
Felix S. Wicke1, Kateryna Karimova1, Ferdinand M. Gerlach1, Michel Wensing3, 
Norbert Smetak4, Ralph F. Bosch5,6 & Martin Beyer1,6
Since 2010, an intensified ambulatory cardiology care programme has been implemented in southern 
Germany. To improve patient management, the structure of cardiac disease management was 
improved, guideline-recommended care was supported, new ambulatory medical services and a 
morbidity-adapted reimbursement system were set up. Our aim was to determine the effects of 
this programme on the mortality and hospitalisation of enrolled patients with cardiac disorders. We 
conducted a comparative observational study in 2015 and 2016, based on insurance claims data. 
Overall, 13,404 enrolled patients with chronic heart failure (CHF) and 19,537 with coronary artery 
disease (CAD) were compared, respectively, to 8,776 and 16,696 patients that were receiving usual 
ambulatory cardiology care. Compared to the control group, patients enrolled in the programme had 
lower mortality (Hazard Ratio: 0.84; 95% CI: 0.77–0.91) and fewer all-cause hospitalisations (Rate 
Ratio: 0.94; 95% CI: 0.90–0.97). CHF-related hospitalisations in patients with CHF were also reduced 
(Rate Ratio: 0.76; 95% CI: 0.69–0.84). CAD patients showed a similar reduction in mortality rates 
(Hazard Ratio: 0.81; 95% CI: 0.76–0.88) and all-cause hospitalisation (Rate Ratio: 0.94; 95% CI: 0.91–
0.97), but there was no effect on CAD-related hospitalisation. We conclude that intensified ambulatory 
care reduced mortality and hospitalisation in cardiology patients.
In high income countries, cardiovascular disease (CVD), despite multiple drug- and device-related therapies 
and improvements in health-related life-styles, remains one of the leading causes of death and  morbidity1. It is 
estimated that CVD is responsible for an annual 3.9 million deaths in  Europe2. Its impact on patients, popula-
tions, and health systems is huge and is the cause of substantial healthcare utilization and cost, most of which is 
due to  hospitalisation3. Furthermore, population ageing is likely to increase the prevalence and impact of CVD. 
Patients with cardiac diseases frequently consult both general practitioners (GPs) and  cardiologists4. However, 
preventable mortality and morbidity often result from poor inter-sectoral  coordination5. Although care coordina-
tion has been shown to optimise disease management, and improve patient  outcomes6,7, notably in ambulatory 
care-sensitive conditions such as heart failure (CHF)8 and coronary artery disease (CAD)9, it is a major challenge 
to improve it within the framework of modern health  systems7.
In Germany, the introduction of such programmes has been facilitated by the creation of a legal framework 
aimed at improving patient management in ambulatory care. In the past decade, ambulatory cardiology care, 
referred to here as the cardiology care programme, has been intensified by establishing voluntary contrac-
tual agreements between healthcare insurers, cardiologists, and GPs. The programme follows the stepped-care 
approach and reflects a renewed focus on GP-centred  care10–12. Core features comprise elements of managed 
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 care13, including the regulation of healthcare provision, selective contracting with healthcare providers, and 
improved access to healthcare for cardiology  patients14. Other elements of the programme (Table 1) include the 
promotion of guideline-recommended care, adherence to quality requirements, continuous quality improvement, 
participation in peer group training sessions, and the use of care pathways to coordinate care. Communication 
between GPs and cardiologists participating in the programme is standardised and requires the mutual exchange 
of important clinical information. The objective of this study was to assess the effect of this cardiology care 
programme on mortality and hospitalisation in enrolled patients with heart failure and coronary artery disease.
Results
Baseline characteristics. Of the 43,712 patients included in this study, 58.3% were male and 41.7% female. 
Mean age was 72.16 (SD 10.67) years, with a high proportion of hypertensive (89.2%), hyperlipidaemic (65.8%), 
and diabetic patients (41.2%). CHF patients were more likely to suffer from atrial fibrillation than CAD patients. 
In contrast, CAD patients were more likely to have a history of myocardial infarction. Overall, 13,404 patients 
with CHF and 19,537 with CAD enrolled in the intensified cardiology care programme, and were compared, 
respectively, to 8,776 and 16,696 control patients that were receiving usual ambulatory cardiology care. Table 2 
displays baseline characteristics by disease cohort. The NYHA class, and Charlson comorbidity index score of 
patients in the intervention group were higher (3.95; SD 2.50) than those in the control group (3.48; SD 2.53).
Care coordination. We assessed the frequency of visits to cardiologists on a quarterly basis for the years 
2015 and 2016. The mean number of quarterly visits to a cardiologist was 3.75 in CHF patients and 3.28 in CAD 
patients, and almost all visits were coordinated (3.72 in CHF patients and 3.23 in CAD patients). In the control 
group, the mean number of quarterly visits to a cardiologist was 3.66 in CHF patients and 3.58 in CAD patients. 
There were noticeable differences in care coordination. Control patients’ consultations with a cardiologist less 
frequently followed a referral from a GP (mean number of coordinated visits 2.44 in CHF patients and 2.32 in 
CAD patients).
All-cause mortality. The results of the multivariable-adjusted model are presented in Fig. 1 and summa-
rised online in Supplementary Tables S2 and S3. Compared to patients receiving usual care, intensified ambu-
latory care for CHF patients was associated with significantly lower all-cause mortality (Hazard Ratio 0.84; 
95% CI 0.77–0.91; p < 0.0001) after adjusting for covariates. This effect was even larger in CAD patients, with a 
Hazard Ratio of 0.81 (95% CI 0.76–0.88; p < 0.0001). Men had increased risk of mortality as did older patients. 
As expected, a higher hazard ratio of death was associated with the presence of atrial fibrillation and greater 
Charlson index score.
Hospitalisation. The results of the multivariable-adjusted regression models for hospitalisation rates are 
presented in Fig. 2 and summarised online in Supplementary Tables S4–S7. Compared to the control group, 
intensified ambulatory care in CHF patients was associated with fewer all-cause hospitalisations (RR 0.94; 95% 
CI 0.90–0.97; p = 0.0009), and CHF-related hospitalisations (Rate Ratio 0.76; 95% CI 0.69–0.84; p < 0.0001). For 
CAD patients, a similar pattern existed for all-cause hospitalisations with a corresponding adjusted Rate Ratio of 
0.94 (95% CI 0.91–0.97; p = 0.0002). However, no association existed between the intervention and CAD-related 
hospitalisations in CAD patients (Rate Ratio 0.96; 95% CI 0.88–1.05; p = 0.3866). Presence of atrial fibrillation 
was consistently associated with an increased risk of hospitalisation. Influenza vaccination was protective, with 
the exception of CAD-related hospitalisation.
Discussion
Ambulatory cardiology patients receive care from both GPs and cardiologists, but poor inter-sectoral coordina-
tion affects health outcomes. In this study of patients with two major cardiac disorders, we examined those that 
received intensified care provided collaboratively by a GP and a cardiac specialist as part of a comprehensive 
Table 1.  Components of the cardiology care programme.
Components of the cardiology care programme
Structured disease management
Promotion of guideline-recommended care
New ambulatory medical services e.g., electrical cardioversion, specially trained healthcare assistants
Morbidity-adapted reimbursement
Incentives for repeat consultations in critical clinical situations and evidence-based pharmacotherapy
Adherence to quality requirements e.g. in diagnostics, a minimum of 100 echocardiograms must be carried out per quarter
Continuous data-driven quality improvement
Participation in clinical peer group training sessions e.g. in drug therapy
Coordinated care pathways with standardised communication between general practitioners and cardiologists
Patient education and emphasis on nationwide disease management programmes
Appointments for regular referrals within two weeks, and urgent referrals the same day
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programme. We found that intensified ambulatory care reduces mortality and the likelihood of hospital admis-
sions. Although the total number of visits to cardiologists was similar, patients receiving intensified cardiology 
care made more coordinated visits than those receiving usual care, which reflects the successful implementa-
tion of the programme. The fact that the cardiology care programme aims to structure care management, to 
increase guideline-oriented care, and to improve  access14, likely contributed towards the reduction in mortality 
and hospitalisations. After adjusting for sociodemographic parameters, health service utilisation, and comor-
bidities, the risk of hospitalisation and mortality was clearly reduced in the intervention group compared with 
Table 2.  Baseline characteristics of patients by disease cohort. Continuous variables are expressed as 
mean ± one SD. Categorical variables are presented as relative frequencies. CAD coronary artery disease, CHF 
chronic heart failure, COPD chronic obstructive pulmonary disease, CVD cardiovascular disease, DMP disease 
management programme, DM diabetes mellitus. a By limiting co-payments, hardship status avoids imposing 
additional financial hardship on chronically ill patients.
Variables
CHF CAD
Intervention group Control group p value Intervention group Control group p value
Number of patients 13,404 8,776 n.a 19,537 16,696 n.a
Sociodemographic parameters
 Mean age (years) 72.9 ± 10.3 74.2 ± 11.4  < 0.0001 72.0 ± 9.9 72.1 ± 10.9 0.168
 Age 18–40, n (%) 76 (0.6) 77 (0.9) 50 (0.3) 79 (0.5)
 Age 41–50, n (%) 372 (2.8) 246 (2.8) 550 (2.8) 578 (3.5)
 Age 51–60, n (%) 1,264 (9.4) 800 (9.1) 2,178 (11.1) 2,017 (12.1)
 Age 61–70, n (%) 2,723 (20.3) 1,495 (17.0) 4,551 (23.3) 3,543 (21.2)
 Age 71–80, n (%) 5,949 (44.4) 3,417 (38.9) 8,572 (43.9) 6,786 (40.6)
 Age 81–90, n (%) 2,855 (21.3) 2,438 (27.8) 3,483 (17.8) 3,388 (20.3)
 Age ≥ 91, n (%) 165 (1.2) 303 (3.5) 153 (0.8) 305 (1.8)
 Sex (% women) 44.8 47.2  < 0.0001 37.1 38.8  < 0.0001
 German nationality (%) 91.5 90.9 0.118 89.1 88.5 0.067
 Living in urban area (%) 46.5 47.2 0.313 48.9 49.0 0.769
 Employed (%) 13.1 12.8 0.478 15.4 17.9  < 0.0001
 Hardship  statusa (%) 30.7 47.9  < 0.0001 29.4 40.6  < 0.0001
 In need of nursing care (%) 11.6 23.0  < 0.0001 8.4 12.9  < 0.0001
 Nursing home resident (%) 0.6 3.1  < 0.0001 0.3 1.3  < 0.0001
Health services utilisation (%)
 DMP CAD 41.7 22.7  < 0.0001 61.3 36.2  < 0.0001
 DMP DM 36.8 25.7  < 0.0001 37.3 25.9  < 0.0001
 CVD hospitalisation 2014 23.7 37.3  < 0.0001 21.3 27.6  < 0.0001
 Influenza vaccination 49.3 41.7  < 0.0001 47.3 40.1  < 0.0001
Mean Charlson index score 4.6 ± 2.5 4.5 ± 2.6  < 0.003 4.0 ± 2.5 3.4 ± 2.6  < 0.0001
NYHA class (%)
 I/unknown 36.1 47.5  < 0.0001 63.8 79.8  < 0.0001
 II 30.1 18.5 16.9 7.0
 III/IV 23.7 34.1 19.3 13.2
Comorbid condition (%)
 Diabetes mellitus 44.4 43.0 0.035 44.3 40.4  < 0.0001
 Hyperlipidaemia 65.7 60.2  < 0.0001 71.1 68.0  < 0.0001
 Renal failure 25.8 31.3  < 0.0001 20.8 20.0 0.036
 COPD 20.3 21.5 0.024 18.1 16.6  < 0.0001
 Pneumonia in 2014 5.5 9.7  < 0.0001 4.2 5.2  < 0.0001
 Depression 23.6 23.4 0.820 22.7 21.5 0.006
Cardiovascular history (%)
 Hypertension 91.8 90.0  < 0.0001 91.2 88.1  < 0.0001
 CHF 100 100 n.a 47.0 33.2  < 0.0001
 CAD 68.4 63.0  < 0.0001 100 100 n.a
 Atrial fibrillation 36.8 42.1  < 0.0001 26.6 26.0 0.144
 Other arrhythmias 50.4 43.3  < 0.0001 37.8 31.7  < 0.0001
 Valvular heart disease 48.7 40.1  < 0.0001 37.1 29.0  < 0.0001
 Myocardial infarction 24.4 21.4  < 0.0001 32.0 29.4  < 0.0001
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usual care. According to our covariates, we obtained results similar to those of other studies. Several studies have 
demonstrated an association between atrial fibrillation and increased risk of hospitalisation and  mortality15–17. 
Pocock et al. identified age as the most powerful predictor of mortality and hospitalisation in CHF  patients18.
The cardiology care programme is inherently multi-component. It is therefore impossible to determine the 
individual importance of each of the individual elements. However, the cardiology care programme employed 
many components of managed care that have been identified as contributing towards improving health 
 outcomes19,20. Firstly, as the programme promotes evidence-based practice, and provides additional incen-
tives for the use of evidence-based  pharmacotherapy14, participating cardiologists were more likely to provide 
guideline-recommended  care21. Secondly, several services were provided to outpatients for the first time, such as 
electrical cardioversion, pressure wire recording, implantation of cardioverter-defibrillators and loop recorders, 
Figure 1.  Forest plot of multivariable Cox regression models for all-cause mortality in CHF and CAD patients 
enrolled in the cardiology care programme versus control group. The squares and horizontal lines correspond 
to the hazard ratios and 95% confidence intervals. Hazard ratios are adjusted for baseline covariates including 
sociodemographic parameters, health services utilisation, mean Charlson index, NYHA class, comorbid 
conditions, and cardiovascular history as listed in Table 2. CAD, coronary artery disease; CHF, chronic heart 
failure; CI, confidence interval; HR, hazard ratio.
Figure 2.  Forest plot of multivariable negative binomial regression models for hospitalisation in CHF and 
CAD patients enrolled in the cardiology care programme versus control group. The squares and horizontal 
lines correspond to the rate ratios and 95% confidence intervals. Rate ratios are adjusted for baseline covariates 
including sociodemographic parameters, health services utilisation, mean Charlson index, NYHA class, 
comorbid conditions, and cardiovascular history as listed in Table 2. CAD, coronary artery disease; CHF, 
chronic heart failure; CI, confidence interval; RR, rate ratio.
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which may have improved access to essential  care22. Thirdly, as the programme incentivised repeat consultations 
in critical clinical situations, close monitoring may have resulted in earlier investigations and  interventions9. 
The ambulatory monitoring strategy showed particular promise in detecting early warning signs before acute 
decompensation occurred in CHF  patients23, hence preventing heart-failure-related  readmissions24. Frequent 
patient-cardiologist interaction may also promote a variety of beneficial activities, such as preventive counselling, 
and nutritional assessments. Furthermore, as participation in the programme is linked to certain requirements 
such as the use of continuous data-driven quality improvement, participating cardiologists probably had greater 
expertise than those providing usual care. Process evaluation based on interviews with  cardiologists25 suggests 
that cardiology practices in the programme initiated little change in their medical  care25, with the interviewed 
cardiologists typically saying the quality of care they provided was already very good. The difference between 
intervention and control groups may therefore not result solely from the programme itself but partly reflect the 
selection of the ‘best physicians’ for participation. CAD-related hospitalisations were not reduced. However, 
since disease management programmes have been offered to CAD patients in southern Germany for more than 
a  decade26, further improvements may be difficult to achieve.
Previous studies have focused on coordinated care in transitional  care8,9,27,28. Particularly in high-risk patients 
with heart failure, randomized controlled studies have shown transitional care to be more clinically-effective and 
cost-effective than usual  care8,27. Among these interventions, targeted care coordination was found to decrease 
hospitalisation and  mortality8,9,27. The vast majority of coordinated care interventions focus on single-disease 
 management29. The cardiology programme evaluated here, however, aims to provide high-quality healthcare 
delivery to a broader spectrum of ambulatory patients with varying cardiac disorders. We examined a wide range 
of important outcomes that are sensitive to ambulatory care for two major cardiac conditions. Our study provides 
useful insights into coordination between primary and secondary care, and the programme has demonstrated 
great promise in improving clinical and economic outcomes for a variety of cardiac  conditions21. Models such as 
patient-centred medical  homes30, and Accountable Care Organizations (ACO) in the Medicare Shared Savings 
Programme in the United  States31 come closest to the cardiology care programme. But both accentuate primary 
care, without the deeper involvement of  cardiologists32. Our results are consistent with the findings of  ACO33.
Strengths of the study include its real-world population-based approach, sophisticated data analysis, and 
large sample size. The large sample size allowed us to adjust for many potential confounders. Use of claims data 
eliminated recall bias and allowed the programme to be evaluated objectively. However, the study was limited 
by our reliance on data (e.g., miscoding of NYHA classification). As data on cause of death were not available, 
it was not possible to conduct a more detailed analysis of the observed association of the programme with mor-
tality. Furthermore, residual confounding from unmeasured confounders cannot be excluded. Finally, since 
participation in the cardiology contract is voluntary, we cannot exclude a self-selection bias by both patients 
and participating physicians. Although we used various covariates that we think will have controlled for selec-
tion bias, it is possible that a high number of very-low-risk patients and few high-risk patients were included in 
the programme. To ensure a representative sample of patients that actually require cardiac care, the selection of 
patients for both the control and intervention groups was based on patients that were being seen by a cardiologist. 
Regardless of participation in the programme, the overall quality of cardiovascular care in Baden-Wuerttemberg 
is high in comparison to other federal states in  Germany34. In order to test the external validity of our results, 
demonstration projects of the coordinated care approach should be used in other German states, whereby their 
focus should also be on investigating ways of enhancing the sustainability of cardiology care.
Methods
Study design and participants. Based on routinely available claims data from the statutory health insur-
ance fund ‘Allgemeine Ortskrankenkasse’ (AOK), a comparative observational study was conducted at the 
state level in Baden-Wuerttemberg, Germany, from 2015 to 2016. Baden-Wuerttemberg has about 11 million 
 inhabitants35. AOK is the largest health insurance fund in this federal state, covering about 40% of the population 
at the time the study was conducted. About 70% of cardiologists and 15% of AOK-insured patients in Baden-
Wuerttemberg participated in the cardiology  programme25. Enrolled patients were compared with non-enrolled 
patients receiving usual care in ambulatory cardiology practices. We identified patients with diagnoses of CHF, 
CAD, or both, coded in accordance with the 10th Revision of the International Classification of Diseases. The 
two disease cohorts were created independently of one another and were not mutually exclusive. Eligible patients 
were ≥ 18 years of age, lived in Baden-Wuerttemberg, and were insured at the AOK without interruption during 
the observation period. Participation in nationwide disease management programmes for patients with chronic 
conditions (including diabetes, asthma/chronic obstructive pulmonary disease, and CAD) was not an exclusion 
criterion and was encouraged. Patients that were not seeing a cardiologist, or that switched groups during the 
observation period, were excluded (n = 260,897). Disease status and baseline characteristics of patients were 
recorded for a pre-observation period in 2014. Outcomes were assessed for a combination of the years 2015 and 
2016.
The intervention group comprised eligible patients that had enrolled in the cardiology care programme and 
had seen a cardiologist that was a contract partner in the programme at least once during the pre-observation 
year 2014. The patients that were assigned to the control group had enrolled in neither the programme nor the 
GP-centred healthcare programme of the AOK, and had received usual care from a cardiologist that did not 
participate in the programme at least once during 2014. All patients enrolled in the programme gave their written 
informed consent before participation. Ethical approval was obtained from the local ethics committees of the 
Department of Medicine of Goethe-University in Frankfurt (No. 291/17). Reports on this observational study, 
which is part of an extensive evaluation report on collaborative care in Germany, were prepared in accordance 
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with STROBE Statement and the German standard for secondary data analysis (STROSA)36. The evaluation has 
been registered at the German Clinical Trials Register (No. DRKS00014859).
Cardiology care programme. The aim of the cardiology care programme is to manage chronic cardiac 
conditions, and improve health outcomes through intensified cardiology care and collaboration between health-
care providers. It is one of the medical specialist programmes that were developed as a part of a previously 
described special programme to enhance primary care (GP-centred healthcare programme)10–12 and only avail-
able to its participants. More than 1.6 million patients have enrolled in AOK Baden-Wuerttemberg’s GP-centred 
healthcare  programme21. Enrolment in the specialist programme is voluntary for both patients and special-
ists. Enrolled patients only consult specialists that are contract partners in the programme, and specialist care 
requires referral by a GP (except for emergencies, gynaecologists, ophthalmologists, and paediatricians)14. This 
gate-keeping system aims to reduce the number of unnecessary specialist consultations.
The programme has its conceptual basis in the managed care approach to medicine. It combines struc-
tured medical care management with a renewed emphasis on guideline-recommended  care14. It also makes new 
ambulatory medical services available, such as electrical cardioversion, pressure wire recording, implantation 
of cardioverter-defibrillators and loop recorders, as well as specially trained and certified healthcare assistants. 
Core elements of the programme for cardiologists are that physicians meet quality requirements, e.g. they base 
necessary adjustments on a data-driven improvement system, and participate regularly in clinical peer group 
training sessions involving GPs. Using a morbidity-adapted reimbursement system, additional incentives are 
available for repeat visits in various critical situations (e.g., cardiac decompensation), as well as evidence-based 
and cost-effective pharmacotherapy. Participating cardiologists work collaboratively with GPs in GP-centred 
healthcare programmes to generate individualised, disease-specific care pathways for patients, which take into 
consideration information such as medical history, medication lists, test results, and patient preferences. The 
fact that healthcare assistants work in concert with GPs and cardiologists likely contributed towards improving 
service coordination, including the transfer of information between providers. Regulations on documentation, 
clinical guideline adherence, and involvement of patients in the healthcare team promise to make care more 
comprehensive. Key features of the cardiology programme from the patient’s perspective include high continu-
ity of care over time, patient education with an emphasis on nationwide disease management programmes, and 
prompt access to ambulatory cardiology care following GP-referral. Prompt access means a specialist appoint-
ment takes place within two weeks, or on the same day in urgent cases, and waiting times are shorter.
Outcomes. The primary outcome in this study was all-cause mortality. For the cohort of CHF patients, 
secondary outcomes included all-cause, and CHF-related hospitalisations. Similarly, secondary outcomes for 
the CAD cohort were hospitalisation for all causes, and CAD-related hospitalisation. These outcome measures 
have been extensively validated in a previously published  work37. We also documented frequency of visits to car-
diologists on a quarterly basis, and coordinated contacts with cardiologists defined as cardiology consultations 
following GP referral. All measures were based on administrative data.
Statistical analysis. For the purpose of data presentation, descriptive statistics were employed for the two 
disease cohorts. Between-group differences were statistically tested. Pearson’s chi-square test was used for cat-
egorical and binary variables (e.g. sex), and the t-test for continuous variables (e.g. age). Comparisons of out-
comes in intervention and control groups were performed separately for each disease cohort. We applied multi-
variable analyses to deal with imbalances between the groups, and adjusted for differences in baseline variables 
(measured in year 1 of the observation period), i.e. sociodemographic parameters, health service utilisation, 
cardiovascular and non-cardiovascular comorbidities (Table 2). The 41 to 50 age-group was used as the refer-
ence category since the prevalence of cardiovascular risk factors in those over age 40  rises38. The Charlson index 
was used to summarize the burden of  comorbidity39. The selection of variables for analysis was based on medi-
cal knowledge and availability in the administrative data, and they were defined in the same way as in previous 
evaluations (see Supplementary Table S1 online)10,12. No statistical criteria was used for selection of variables for 
the multivariable analysis. The negative binomial regression model and the Cox regression model were used to 
calculate, respectively, risk ratio for hospitalisation and hazard ratios for mortality. We tested for misspecifica-
tion, e.g. the effects of separation and multicollinearity, in accordance with Good Practice in Secondary Data 
Analysis (GPS)40. Effects were expressed with 95% confidence intervals and two-tailed p-values. All descriptive 
and comparative analyses were carried out using SAS (version 9.4) and IBM SPSS Statistics (version 25).
Data availability
AOK Baden-Wuerttemberg can be contacted for secondary analyses of their administrative data.
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